Introduction：Bulgaria's orthopedic device procurement is undergoing rapid change. Driven by Ministry of Health efficiency mandates and НЗОК budget constraints, major public and private hospitals prioritize implants that are clinically effective, regulatory compliant, and cost-predictable.This guide profiles 15 leading intramedullary nail manufacturers active in Bulgaria, based on their core portfolios, technological strengths, and market positioning, to support informed procurement decisions.

Introduction：Belgium's orthopedic device procurement is undergoing rapid change. Driven by cost-containment mandates from the Federal Public Service (FPS) Public Health and high trauma volumes managed by major hospital networks—such as ZNA/GZA, CHC, UZ Leuven, and Saint-Luc—procurement boards increasingly prioritize implants that are clinically effective, regulatory compliant, and cost-predictable.This guide profiles 15 leading intramedullary nail manufacturers active in Belgium, based on their core portfolios, technological strengths, and market positioning, to support informed decisions under the Belgian Public Procurement Law framework.

Introduction：Portugal's orthopedic device procurement is undergoing rapid change. Driven by cost-containment mandates from the Ministry of Health (Ministério da Saúde) and high trauma volumes managed by Local Health Units (ULS) under the National Health Service (SNS)—alongside major private hospital groups like Luz Saúde, CUF, and Lusíadas Saúde—procurement boards increasingly prioritize implants that are clinically effective, regulatory compliant, and cost-predictable.This guide profiles 15 leading intramedullary nail manufacturers active in Portugal, based on their core portfolios, technological strengths, and market positioning, to support informed decisions under the Public Tenders (Concursos Públicos) framework and the centralized purchasing authority SPMS (Serviços Partilhados do Ministério da Saúde).

Introduction：Spain's orthopedic device procurement is undergoing rapid change. Driven by cost-containment mandates from the Ministry of Health (Ministerio de Sanidad) and high trauma volumes managed by autonomous community health services—such as SERMAS (Madrid), SAS (Andalucía), Catsalut (Cataluña), and SACYL (Castilla y León)—alongside major private hospital groups like Quirónsalud and Vithas, procurement boards increasingly prioritize implants that are clinically effective, regulatory compliant, and cost-predictable.This guide profiles 15 leading intramedullary nail manufacturers active in Spain, based on their core portfolios, technological strengths, and market positioning, to support informed decisions under the Public Tenders (Licitaciones Públicas) framework.